Matthew D. Dallas, VP, Finance at AVEO PHARMACEUTICALS INC (AVEO), sold 3,075 shares at $0.82 ($3K) on 2015-01-16, disclosed to the SEC on 2015-01-20.
Scheduled sale ($3k) by VP, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVEO | SELL | 2015-01-08 | $415 | — | Filing → |